User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Antiphospholipid syndrome : Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

Primary tabs

Cervera, Ricard Piette, Jean-Charles Font, Josep Khamashta, Munther A. Shoenfeld, Yehuda Houssiau, Frédéric [UCL] Ingelmo, Miguel

Objective. To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS) in a large cohort of patients and to define patterns of disease expression. Methods. The clinical and serologic features of APS (Sapporo preliminary criteria) in 1,000 patients from 13 European countries were analyzed using a computerized database. Results. The cohort consisted of 820 female patients (82.0%) and 180 male patients (18.0%) with a mean +/- SD age of 42 +/- 14 years at study entry. "Primary" APS was present in 53.1% of the patients; APS was associated with systemic lupus erythematosus (SLE) in 36.2%, with lupus-like syndrome in 5.0%, and with other diseases in 5.9%. A variety of thrombotic manifestations affecting the majority of organs were recorded. A catastrophic APS occurred in 0.8% of the patients. Patients with APS associated with SLE had more episodes of arthritis and livedo reticularis, and more frequently exhibited thrombocytopenia and leukopenia. Female patients had a higher frequency of arthritis, livedo reticularis, and migraine. Male patients had a higher frequency of myocardial infarction, epilepsy, and arterial thrombosis in the lower legs and feet. In 28 patients (2.8%), disease onset occurred before age 15; these patients had more episodes of chorea and jugular vein thrombosis than the remaining patients. In 127 patients (12.7%), disease onset occurred after age 50; most of these patients were men. These patients had a higher frequency of stroke and angina pectoris, but a lower frequency of livedo reticularis, than the remaining patients. Conclusion. APS may affect any organ of the body and display a broad spectrum of manifestations. An association with SLE, the patient's sex, and the patient's age at disease onset can modify the disease expression and define specific subsets of APS.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2002
Language Anglais
Journal information "Arthritis & Rheumatism" - Vol. 46, no. 4, p. 1019-1027 (2002)
Peer reviewed yes
Publisher Wiley-liss (New York)
issn 0004-3591
e-issn 1529-0131
Publication status Publié
Affiliations UCL - (SLuc) Service de rhumatologie
UCL - MD/MINT - Département de médecine interne
MESH Subject Sex Distribution ; Prevalence ; Middle Aged ; Male ; Lupus Vasculitis, Central Nervous System - diagnosis - epidemiology - immunology ; Infant, Newborn ; Infant ; Humans ; Female ; Diagnosis, Differential ; Cohort Studies ; Child, Preschool ; Child ; Autoantibodies - blood ; Antiphospholipid Syndrome - diagnosis - epidemiology - immunology ; Aged, 80 and over ; Aged ; Age Distribution ; Adult ; Adolescent
Links
  1. Asherson, The antiphospholipid syndrome, 3 (1996)
  2. ASHERSON RONALD A., KHAMASHTA MUNTHER A., ORDI-ROS JOSE, DERKSEN RONALD H. W. M., MACHIN SAMUEL J., BARQUINERO JORGE, OUTT HARRY H., HARRIS E. NIGEL, VILARDELL-TORRES MIGUEL, HUGHES GRAHAM R. V., The “Primary” Antiphospholipid Syndrome : Major Clinical and Serological Features, 10.1097/00005792-198911000-00004
  3. Asherson Ronald A., Cervera Ricard, Piette Jean-Charles, Font Josep, Lie J. T., Burcoglu Arsinur, Lim Ken, Muñoz-Rodríguez Francisco J., Levy Roger A., Boué François, Rossert Jérôme, Ingelmo Miguel, Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients : , 10.1097/00005792-199805000-00005
  4. ALARCÓN-SEGOVIA DONATO, DELEZÉ MARGARITA, ORIA CARMEN V., SÁNCHEZ-GUERRERO JORGE, GÓMEZ-PACHECO Luis, CABIEDES JAVIER, FERNÁNDEZ LUIS, DE LEÓN SERGIO PONCE, Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients : , 10.1097/00005792-198911000-00003
  5. Cervera R, Font J, Lopez-Soto A, Casals F, Pallares L, Bove A, Ingelmo M, Urbano-Marquez A, Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients., 10.1136/ard.49.2.109
  6. Mackworth-Young C G, Loizou S, Walport M J, Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder., 10.1136/ard.48.5.362
  7. Font Josep, Loapez-Soto Alfons, Cervera Ricard, Balasch Joan, Pallarés Lucio, Navarro Margarita, Bosch Xavier, Ingelmo Miguel, The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients, 10.3109/08916939108997126
  8. Vianna Joao L., Khamashta Munther A., Ordi-Ros Jose, Font Jose, Cervera Ricard, Lopez-Soto Alfonso, Tolosa Carlos, Franz Juliane, Selva Alberto, Ingelmo Miguel, Vilardell Miguel, Hughes Graham R.V., Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients, 10.1016/0002-9343(94)90108-2
  9. Sammaritano, The antiphospholipid syndrome, 259 (1996)
  10. Wilson Wendell A., Gharavi Azzudin E., Koike Takao, Lockshin Michael D., Branch D. Ware, Piette Jean-Charles, Brey Robin, Derksen Ronald, Harris E. Nigel, Hughes Graham R. V., Triplett Douglas A., Khamashta Munther A., International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop, 10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f
  11. Tan Eng M., Cohen Alan S., Fries James F., Masi Alfonse T., Mcshane Dennis J., Rothfield Naomi F., Schaller Jane Green, Talal Norman, Winchester Robert J., The 1982 revised criteria for the classification of systemic lupus erythematosus : REVISED CRITERIA FOR SLE, 10.1002/art.1780251101
  12. Arnett Frank C., Edworthy Steven M., Bloch Daniel A., Mcshane Dennis J., Fries James F., Cooper Norman S., Healey Louis A., Kaplan Stephen R., Liang Matthew H., Luthra Harvinder S., Medsger Thomas A., Mitchell Donald M., Neustadt David H., Pinals Robert S., Schaller Jane G., Sharp John T., Wilder Ronald L., Hunder Gene G., The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, 10.1002/art.1780310302
  13. Bohan Anthony, Peter James B., Polymyositis and Dermatomyositis, 10.1056/nejm197502132920706
  14. Masi Alfonse T., , Preliminary criteria for the classification of systemic sclerosis (scleroderma), 10.1002/art.1780230510
  15. Vitali Claudio, Bombardieri Stefano, Moutsopoulos Haralampos M., Balestrieri Genesio, Bencivelli Walter, Bernstein Robert M., Bjerrum Kirsten B., Braga Susanna, Coll Joaquin, Vita Salvatore De, Drosos Alexandros A., Ehrenfeld Michael, Hatron Pierre Y., Hay Elaine M., Isenberg David A., Janin Anne, Kalden Joachim R., Kater Louis, Konttinen Yrjö T., Maddison Peter J., Maini Ravinder N., Manthorpe Rolf, Meyer Olivier, Ostuni Pierantonio, Pennec Yvon, Prause Jan U., Richards Andrea, Sauvezie Bernard, Schiødt Morten, Sciuto Maria, Scully Crispian, Shoenfeld Yehuda, Skopouli Fotini N., Smolen Josef S., Snaith Michael L., Tishler Moshe, Todesco Silvano, Valesini Guido, Venables Patrick J. W., Wattiaux Marie J., Youinou Pierre, Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community, 10.1002/art.1780360309
  16. Hunder Gene G., Arend William P., Bloch Daniel A., Calabrese Leonard H., Fauci Anthony S., Fries James F., Leavitt Randi Y., Lie J. T., Lightfoot Robert W., Masi Alfonse T., McShane Dennis J., Michel Beat A., Mills John A., Stevens Mary Betty, Wallace Stanley L., Zvaifler Nathan J., The American College of Rheumatology 1990 criteria for the classification of vasculitis: Introduction, 10.1002/art.1780330802
  17. The antiphospholipid syndrome (1996)
  18. Ad Hoc Committee on Classification of Headaches, Cephalalgia, 8, 1 (1988)
  19. Harris, Clin Exp Immunol, 68, 215 (1987)
  20. Brandt, Thromb Haemost, 74, 1185 (1995)
  21. Harris E.Nigel, Pierangeli Silvia S, ‘Equivocal’ Antiphospholipid Syndrome, 10.1006/jaut.2000.0419
  22. Lockshin Michael D., Sammaritano Lisa R., Schwartzman Sergio, Validation of the Sapporo criteria for antiphospholipid syndrome, 10.1002/1529-0131(200002)43:2<440::aid-anr26>3.0.co;2-n
  23. Khamashta Munther A., Cuadrado Maria Jose, Mujic Fedza, Taub Nick A., Hunt Beverley J., Hughes Graham R.V., The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome, 10.1056/nejm199504133321504
  24. Muñoz-Rodríguez Francisco J., Font Josep, Cervera Richard, Reverter Joan Carles, Tàssies Dolors, Espinosa Gerard, López-Soto Alfonso, Carmona Francisco, Balasch Joan, Ordinas Antoni, Ingelmo Miguel, Clinical study and follow-up of 100 patients withthe antiphospholipid syndrome, 10.1016/s0049-0172(99)80029-8
  25. Balasch Juan, Carmona Francisco, López-Soto Alfonso, Font José, Creus Montserrat, Fabregues Francisco, Ingelmo Miguel, Vanrell Juan A., Pregnancy: Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome, 10.1093/oxfordjournals.humrep.a138009
  26. Branch, Obstet Gynecol, 80, 614 (1992)
  27. DERKSEN R H W M, How to treat women with antiphospholipid antibodies in pregnancy?, 10.1136/ard.60.1.1
  28. Rai R, Cohen H, Dave M, Regan L, Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies), 10.1136/bmj.314.7076.253
  29. Harris E. Nigel, Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia : Predictive Value of the Anticardiolipin Antibody Test, 10.1001/archinte.1986.00360230069012
  30. Asherson, The antiphospholipid syndrome, 249 (1996)
  31. CERVERA RICARD, KHAMASHTA MUNTHER A., FONT JOSEP, SEBASTIANI GIAN DOMENICO, GIL ANTONIO, LAVILLA PAZ, DOMÉNECH INÉS, AYDINTUG A. OLCAY, JEDRYKA-GÓRAL ANNA, RAMÓN ENRIQUE DE, GALEAZZI MAURO, HAGA HANS-JACOB, MATHIEU ALESSANDRO, HOUSSIAU FRÉDÉRIC, INGELMO MIGUEL, HUGHES GRAHAM R.V., Systemic Lupus Erythematosus : Clinical and Immunologic Patterns of Disease Expression in a Cohort of 1,000 Patients, 10.1097/00005792-199303000-00005
  32. Asherson, J Rheumatol, 19, 508 (1992)
  33. Francès Camille, Piette Jean-Charles, Saada Véronique, Papo Thomas, Wechsler Bertrand, Chosidow Olivier, Godeau Pierre, Multiple Subungual Splinter Hemorrhages in the Antiphospholipid Syndrome: A Report of Five Cases and Review of the Literature, 10.1177/096120339400300212
  34. Cervera Ricard, Khamashta Munther A., Font Josep, Reyes Pedro A., Vianna João L., López-Soto Alfons, Amigo Mary-Carmen, Asherson Ronald A., Azqueta Manuel, Paré Carles, Vargas Jesús, Romero Angel, Ingelmo Miguel, Hughes Graham R.V., High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome, 10.1177/096120339100100108
  35. Nochy Dominique, Daugas Eric, Huong Du Le Thi, Piette Jean-Charles, Hill Gary, Kidney Involvement in the Antiphospholipid Syndrome, 10.1006/jaut.2000.0423
Bibliographic reference Cervera, Ricard ; Piette, Jean-Charles ; Font, Josep ; Khamashta, Munther A. ; Shoenfeld, Yehuda ; et. al. Antiphospholipid syndrome : Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. In: Arthritis & Rheumatism, Vol. 46, no. 4, p. 1019-1027 (2002)
Permanent URL http://hdl.handle.net/2078.1/42044